In order to help patients fight cancer, we believe in the combination of high-quality
treatments delivered by cancer experts and a comprehensive patient-centered care.
We care for our patients passionately. We design personalized treatments and deliver integrative cancer care.
Because each patient is unique (physically, psychologically, socially), we design personalized and comprehensive cancer care, including complementary therapies (such as nutrition or psychological support) to help patients feel better while they are having treatment at Amethyst, our focus is on patient, as we are convinced that good patient experience is linked to improved patient outcomes.
Take a look at the history of the group
Foundation of Amethyst Radiotherapy, by Ludovic Robert and the Goldenberg family, who have been active in the healthcare and pharma markets in Europe for the past 35 years.
First Amethyst radiotherapy center in Italy is established through a partnership with the Fatebenefratelli Order in Rome and is located on the Tiber Island.
Construction of new bunker in La Garenne-Colombes - equipped with a new Varian Truebeam linac - and investment in new Saginova equipment for brachytherapy
Extension of the Compiègne clinic, equipped with state-of-the-art equipment, including a Varian Trubeam linac
Major upgrade investment at Maubeuge clinic (installation of new Elektra Versa HD accelerator, scanner upgrade and new Raysearch TPS software)
Upgrade of Creil equipment (new Varian Truebeam linac and Exactrac position control system)
The Rohatyn Group invests in Amethyst Radiotherapy to accelerate the growth of the Company across Europe through the roll-up of clinics, the development of greenfield centers and outsourcing partnerships with hospitals.
Amethyst Radiotherapy expands its footprint into the UK through the acquisition of Medical Equipment Solutions Limited (MESL), a specialised provider of intracranial radiation treatments at Queen Square Radiosurgery Center in London and Thornbury Radiosurgery Center in Sheffield.
Third linear accelerator installed in Bucharest clinic, giving the center the capacity to treat 240 radiotherapy patients each day.
The Amethyst story has been shaped by the ambition to make the latest radiotherapy technologies available to all patients across Europe and from other parts of the world.
Amethyst is a fast-growing network of radiotherapy clinics in Europe.
We operate 11 centers across Austria, France, Italy, Poland, Romania and more recently UK. High-tech radiotherapy is at the core of all Amethyst Radiotherapy clinics and we strive to offer oncological patients access to the best and the fastest treatments available. Amethyst is set to continue its fast growth and reach 50 clinics and over 100 linear accelerators in the medium term to become a worldwide leader in the fight against cancer.
Research & Clinical Trials
Clinical trials aim to develop better therapies for significant conditions such as cancer. Over time, it has been demonstrated that these trials, with the participation of a large number of patients, are the only way to find out if a new treatment is better than the existing standard of care and enable people facing cancer to get high quality treatment and care. The implementation of the results of these studies in current medical practice saves millions of lives worldwide every year.
National, European and International clinical trials are conducted according to very strict medical and legal rules and regulations, in order to minimise any serious or even fatal adverse reactions.
Amethyst is at the forefront of medical research in Europe.